I mercati dell'Italia chiudono fra 25 minuti

FTSE MIB
34.704,26
+294,92(+0,86%)
Dow Jones
42.563,02
+387,91(+0,92%)
Nasdaq
18.184,65
-5,64(-0,03%)
Nikkei 225
39.829,56
+903,93(+2,32%)
Petrolio
67,98
+0,31(+0,46%)
Bitcoin EUR
59.280,83
+1.630,84(+2,83%)

IOVA Jan 2026 17.000 put

OPR - OPR Prezzo differito. Valuta in USD.

Aggiungi a watchlist

9,47

0,00

(0,00%)

In data: 11:05AM EDT. Mercato aperto.

GlobeNewswire
Iovance Biotherapeutics Announces Clinical Data for Lifileucel in Advanced Mucosal Melanoma at the European Society for Medical Oncology (ESMO) Congress
SAN CARLOS, Calif., Oct. 16, 2023 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with cancer, today announced the publication of an abstract reporting clinical data for lifileucel which will be presented at the European Society for Medical Oncology ESMO Congress 2023, October 20-24, 2023 in Madrid, Spain. The abstract reports out